PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

The market may start to fink ahead and realise its potential for...

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    The market may start to fink ahead and realise its potential for being a "nice little earner"

    @hamman, there will be sweet spot for iPPS's durability. This will allows our TAM to compound each year as existing patients get retreated and new ones also come in. I note that vets typically give 4 shots over 4 weeks then admin monthly


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.